Updates | ClinRegs

Brazil: ANVISA Issues Updated Guidelines Related to COVID-19 and Clinical Trials

Aug 4, 2020 - On July 28, 2020, Brazil’s National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária (ANVISA)) issued an updated technical note providing guidance to sponsors, centers, and researchers related to clinical research and COVID-19. The ...

Mali Profile Reviewed

Jul 23, 2020 - The Mali profile in ClinRegs has been reviewed to ensure all information is up-to-date and accurate. ...

Guinea Profile Reviewed

Jul 17, 2020 - The Guinea profile in ClinRegs has been reviewed to ensure all information is up-to-date and accurate. ...

China Profile Updated in ClinRegs

Jul 7, 2020 - The China profile in ClinRegs now includes the National Medical Products Administration’s (NMPA) revised Measures for the Administration of Drug Registration, which took effect July 1, 2020. Please note that NMPA has also released the following requirements which took ...

Peru: INS Issues Guidelines for Clinical Trials during COVID-19 Emergency

Jul 7, 2020 - On June 26, 2020, Peru’s National Institute of Health (Instituto Nacional de Salud (INS)) issued Guidelines for the Conduct of Clinical Trials during the Health Emergency Due to COVID-19. The guidelines aim to assist sponsors in assuring the safety of trial participants, maintaining ...

Liberia Profile Reviewed

Jul 2, 2020 - The Liberia profile in ClinRegs has been reviewed to ensure all information is up-to-date and accurate. ...

Kenya Profile Updated in ClinRegs

Jun 26, 2020 - The Kenya profile in ClinRegs now includes the following updates: Amendments to the Pharmacy and Poisons Act, enacted through the Health Laws (Amendment) Act, 2019 (See Regulatory Authority and Investigational Products topics) An updated version ...